Akero Therapeutics Inc (NASDAQ: AKRO) is 85.01% higher on its value in year-to-date trading and has touched a low of $15.32 and a high of $58.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AKRO stock was last observed hovering at around $51.71 in the last trading session, with the day’s loss setting it -0.24%.
Currently trading at $51.47, the stock is 81.33% and 74.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.23 million and changing -0.46% at the moment leaves the stock 95.99% off its SMA200. AKRO registered 133.32% gain for a year compared to 6-month gain of 83.04%. The firm has a 50-day simple moving average (SMA 50) of $29.1283 and a 200-day simple moving average (SMA200) of $26.113525.
The stock witnessed a 80.22% loss in the last 1 month and extending the period to 3 months gives it a 79.03%, and is 101.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.23% over the week and 6.58% over the month.
Akero Therapeutics Inc (AKRO) has around 56 employees, a market worth around $3.59B and $0.00M in sales. Distance from 52-week low is 235.97% and -11.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.65%).
The EPS is expected to shrink by -39.67% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Akero Therapeutics Inc (AKRO) Top Institutional Holders
249.0 institutions hold shares in Akero Therapeutics Inc (AKRO), with institutional investors hold 112.81% of the company’s shares. The shares outstanding are 69.61M, and float is at 58.32M with Short Float at 5.74%. Institutions hold 106.52% of the Float.
The top institutional shareholder in the company is JANUS HENDERSON GROUP PLC with over 6.88 million shares valued at $161.28 million. The investor’s holdings represent 11.5942% of the AKRO Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.59 million shares valued at $131.06 million to account for 9.4197 of the shares outstanding. The other top investors are RTW INVESTMENTS, LP which holds 5.43 million shares representing 9.159% and valued at over $127.43 million, while GENERAL ATLANTIC, L.P. holds 8.8251 of the shares totaling 5.23 million with a market value of $122.79 million.
Akero Therapeutics Inc (AKRO) Insider Activity
#####
Still, SEC filings show that on Jan 27 ’25, PATRICK D LAMY (Officer) Proposed Sale 6,000 shares at an average price of $26.18 for $0.16 million. The insider now directly holds shares of Akero Therapeutics Inc (AKRO).
